4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA since June 8:

Advertisement

1. Diflorasone diacetate ointment is a topical steroid used to treat pain, itching and swelling caused by skin diseases.

2. Moxidectin is a treatment for onchocerciasis, also known as river blindness, which is a skin and eye disease caused by a parasitic worm.

3. Keytruda may now be used to treat patients with recurrent or metastatic cervical cancer. The drug also gained approval to treat adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma.

4. Buprenorphine and naloxone sublingual film is the first generic version of Suboxone used to treat opioid dependence.

More articles on supply chain:

Flex Pharma to slash 60% of workforce, consider sale or merger
Almost two-thirds of consumers think product recalls are just ‘red tape’
J&J divests LifeScan unit for $2.1B: 3 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.